Literature DB >> 28700984

Immunosuppressive Treatment in C3 Glomerulopathy: Time to Reconsider Our Approach.

Vladimir Tesar1, Zdenka Hruskova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28700984     DOI： 10.1159/000479014

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN： 0250-8095            Impact factor:   3.754


× No keyword cloud information.
  3 in total

1.  Diagnostic Dilemma of Paraneoplastic Rheumatic Disorders: Case Series and Narrative Review.

Authors:  Youngmin Cho; Erik W Anderson; Sara J Guevara; Santiago J Miyara; Naomi Maria; Christine N Metz; Stefanos Zafeiropoulos; Dimitrios Giannis; Jifeng Wang; Oluseyi Abidoye; James M Mumford; Judith Aronsohn; Ernesto Molmenti; Huma Sohail
Journal:  Cureus       Date:  2021-11-29

2.  Clinicopathological features of C3 glomerulopathy in children: a single-center experience.

Authors:  Keri A Drake; Natalie Ellington; Jyothsna Gattineni; Jose R Torrealba; Allen R Hendricks
Journal:  Pediatr Nephrol       Date:  2019-10-30       Impact factor: 3.714

3.  Infection-related Glomerulonephritis and C3 Glomerulonephritis - Similar Yet Dissimilar: A Case Report and Brief Review of Current Literature.

Authors:  Gajapathiraju Chamarthi; William L Clapp; Harini Bejjanki; Jena Auerbach; Abhilash Koratala
Journal:  Cureus       Date:  2020-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.